January 23, 2017
RJ Health Systems International LLC must face Bayer HealthCare Pharmaceuticals Inc.'s suit alleging that the drug information company falsely listed the price of Bayer's intrauterine device Mirena as nearly $200 less than it actually costs, leading to lost income for the drugmaker, a New Jersey federal judge said on Friday.
September 21, 2015
Bayer HealthCare Pharmaceuticals Inc. filed suit in New Jersey federal court Friday alleging that a drug-information company conflated prices of the drugmaker's Mirena intrauterine device and Actavis PLC's Liletta, creating potential reimbursement gaps and forcing Bayer to temporarily discount the contraceptive.